Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Index funds win long term largely because of lower costs and broad diversification. This brief introduces the cost advantage and payoff.
27,987 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
As June trading unfolds, Netflix nudges higher on pricing expectations ahead of its July earnings. The broader market...
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
Investors woke up to a surge in Qualcomm stock after the company outlined bold AI-backed growth targets. This article...
If a bear market shows up, you still want to act with confidence. This guide lays out a clear plan and the three stoc...
A year after XRP surged to $3.65, ripple (xrp) peaked $3.65 remains a milestone. Today, the token is far lower as reg...
MSA Safety's Q4 2025 results offer more than a quarterly number. This guide breaks down what safety (msa) 2025 earnin...
Forum Energy's latest earnings reveal how the company balances growth with cash flow in volatile markets. This guide ...
IMAX stock is showing fresh strength after a solid quarterly beat and a clear path to bigger earnings from its premiu...
Oil futures surged to fresh highs, weighing on Nvidia, Amazon, and Meta as energy costs threaten ad budgets and data-...
Marvell Technology stock is moving higher as demand for data center and networking chips strengthens. This guide brea...
A surge in XRP trading on key exchanges has investors buzzing. This sign that better could point to shifting sentimen...